# Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

Study · id `cardio:ct-nct06197022` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06197022](<https://clinicaltrials.gov/study/NCT06197022>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06197022

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

## Technical summary

Registry record NCT06197022. Non-randomized; no masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2024-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 106 participants (planned count; ClinicalTrials.gov record NCT06197022, source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)
- Started: 2022-10-01 (actual) (ClinicalTrials.gov record NCT06197022, source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)
- Primary completion: 2024-10 (anticipated) (ClinicalTrials.gov record NCT06197022, source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)
- Completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT06197022, source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)
- Countries: Bulgaria (ClinicalTrials.gov record NCT06197022, source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06197022-2024-01-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
- Acronym: SCA-DEB
- Condition: Coronary Artery Disease
- Intervention (Device): Mozec™ SEB Sirolimus Eluting Rx PTCA Balloon Dilatation Catheter
- Lead sponsor: University National Heart Hospital
- Lead sponsor class: OTHER
- Collaborator: Meril Life Sciences Pvt. Ltd.
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: Meril Life Sciences Pvt. Ltd. (`cardio:org-meril-life-sciences-pvt-ltd`)

## Provenance

Content hash: 08702c1592a58dc66b2b9b43900d0c595dcf5629f8e661d298e73fb972cfc75a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
